The IRE Resource Center is a major research library containing more than 23,250 investigative stories — both print and broadcast. These stories are searchable online or by contacting the Resource Center directly (573-882-3364 or rescntr@ire.org) where a researcher can help you pinpoint what you need. Browse or search the tipsheet section of our library below. Stories are not available for download but can be easily ordered by contacting the Resource Center:
Search results for "GlaxoSmithKline" ...
-
Side Effects
Side Effects tells the story of a court case and the personal story that surrounded the making and unmasking of a bestselling drug, Paxil. "It chronicles the lives of two women - a prosecutor and a whistleblower - who exposes the pattern of deception in the research and marketing of Paxil, an antidepressant prescribed to millions of children and adults."
Tags: Paxil; FDA; side-effects; GlaxoSmithKline; drug regulators; drug regulation; depression in children; clinical trials; misappropriation;
-
Drug Danger Cover-up? Evidence of Suppressed Information
In a six month investigation of the antidepressant manufacturers, PrimeTime Live uncovered a trail of internal documentation revealing efforts to suppress information regarding serious adverse health risks from consumers and the doctors who prescribe these powerful psychoactive medications. Patients, and parents of juvenile patients, suspected that the drug companies were not coming clean about the negative effects of antidepressants.
Tags: antidepressants; psychoactive medication; suicidal behavior in children; Glaxo SmithKline; Paxil; Vioxx; Wyeth; Effexor; Pfizer; Zoloft
-
Vaccines: An issue of trust; Missed shots
In a two-part investigation Consumer Reports examines the pros and cons in regard to modern-day vaccines. The first part looks at the parents' dilemma: "Do I expose my child and community to the risk of a serious disease? Or do I expose my child to the risk of one of those rare catastrophic reactions to the vaccine itself...?" The story examines some "significant gaps" in the vaccine-safety system, but it also points to studies showing that unimmunized children are many times more likely to contract dangerous disease than vaccinated children. The second part reports on the neglect of adult immunization, and points out that every year as many as 400,000 Americans die of diseases that could have been prevented by routine vaccines.
Tags: polio; immunization; measles; mumps; rubella; doctors; patients; parents; diseases; GlaxoSmithKline; Aventis Pasteur; Wyeth Lederle; Merck
-
New Regimen: AIDS-Drug Price War Breaks Out in Africa, Goaded by Generics
A Wall-Street Journal analysis looks at the AIDS-drug market, and finds that "pharmaceutical giants seek to blunt a growing threat from generic-drug companies and recoup some moral high ground amid the crippling epidemic." The story reports on the slashing of the prices by the biggest drug-makers. It also includes a table of prices for AIDS per patient per year in the U.S. and Africa offered by large drug makers and two Indian generic drug companies.
Tags: Bristol-Myers; Glaxo-SmithKline PLC; Merck; Roche; Boehringer-Ingelheim; United Nations; Cipla; Hetero; developing nations; Third World
-
Doctors on the Run Can 'Dine 'n' Dash' In Style in New Orleans
The Wall Street Journal investigates how the drug companies' marketing events for doctors can impact the physicians' objectivity. The story reveals that in 2000 pharmaceutical firms have spent on this type of direct marketing $4.04 billion, while drug advertising to consumers was estimated at $2.5 billion. The reporter describes how at Christmas time in New Orleans drug makers have gained access to the doctors by inviting them to opulent dinners and letting them win free Christmas trees.
Tags: physicians; drugs; doctors; advertising; marketing; PR; Merck & Co.; Smithkline Beecham; Bayer AG; GlaxoSmithKline; Boehringer Ingelheim Pharmaceuticals Inc.